Use this link to get back to this page.
Copy
For the best user experience on this site, you should have JavaScript enabled in your browser.
Skip to Content
Open Access User
Close
Library Information
Library Website
View Gale Product Menu
Sign in bar
Access through your library
English
Select Language English
Afrikaans
العربية
Bahasa Indonesia
Bahasa Malaysia
česky
Cymraeg
Dansk
Deutsch
English
Español
Français
Gaeilge
Hrvatski
Italiano
magyar
ខ្មែរ
Nederlands
Polski
Português
Română
Slovenščina
slovenský
suomi
svenska
Tagalog
Tiếng Việt
Türkçe
Русский
Ελληνικά
বাংলা
हिंदी
தமிழ்
ไทย
中文(简体)
中文(繁體)
日本語
한국어
Items in
Highlights & Notes
may not have been saved to Google Drive™ or Microsoft OneDrive™. Are you sure you want to logout?
Gale Academic OneFile Select
Toolbar
Please select the search index
Basic Search
Advanced Search
Cite
Send to...
Download
Print
Get Link
Highlights and Notes
Your session has timed out after 20 minutes of inactivity. If you do not click continue session, you will be logged out in 60 seconds
Your session has timed out after 20 minutes of inactivity. If you do not click continue session, you will be logged out in 60 seconds
Association of COVID-19 Vaccination in Pregnancy With Adverse Peripartum Outcomes.
Citation metadata
Authors:
Deshayne B. Fell
,
Tavleen Dhinsa
,
Gillian D. Alton
,
Eszter Torok
,
Sheryll Dimanlig-Cruz
and
Annette K. Regan
Date:
Apr. 19, 2022
From:
JAMA, The Journal of the American Medical Association
(Vol. 327, Issue 15)
Publisher:
American Medical Association
Document Type:
Report
Length:
25 words
Document controls
Translate
Document Translation
Format Options:
Save to Google Drive™
Save to OneDrive™
HTML
Translate Article
Set Interface Language
Decrease font size
Increase font size
Display options
Colors:
Font:
Open Sans
EB Garamond
Open Dyslexic
Noto Sans
Default
More
Most
Line Spacing
Letter Spacing
Word Spacing
Back to Default Settings
Done
Listen
Send to Google Drive™
Send to Microsoft OneDrive™
Email
Download
Print
Main content
Abstract :
The peripartum outcomes following the vaccination of pregnant women against COVID-19 are evaluated. The women received mostly mRNA vaccines during the second and third trimesters.
Source Citation
Source Citation
Gale Document Number:
GALE|A707128719
Explore
Related Subjects
COVID-19 vaccines
Pregnant women